0.5%w/v Metronidazole Injection USP

0.5%w/v Metronidazole Injection USP
Product Description

0.5%w/v  Metronidazole  Injection  USP  is  indicated  in  adults  and  children  when  oral medication is not possible for the following indications: - The prophylaxis of postoperative infections due to sensitive anaerobic bacteria particularly species of Bacteroides and anaerobic Streptococci, during abdominal, gynaecological gastrointestinal or colorectal surgery which carries a high risk of occurrence of this type of infection. The solution may also be used in combination with an antibiotic active against aerobic bacteria. - The treatment of severe intraabdominal and gynaecological infections in which sensitive anaerobic bacteria particularly Bacteriodes and anaerobic Streptococci have been identified or are suspected to be the cause. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 

Qatar Pharma

  • QA
  • 2019
    On CPHI since
Specifications
  • CAS Registry Number
    443-48-1

Qatar Pharma

  • QA
  • 2019
    On CPHI since

More Products from Qatar Pharma (2)

  • 0.5%w/v  Levofloxacin Injection

    Product 0.5%w/v Levofloxacin Injection

    0.5% w/v Levofloxacin Injection is indicated in adults for the treatment of the following infections : Community-acquired pneumonia, Complicated skin and soft tissue infection. For the above-mentioned infections 0.5% w/v Levofloxacin Injection should be used only when it is considered inappropria...
  • 1%w/v & 2%w/v  Lidocaine Hydrochloride Injection, USP

    Product 1%w/v & 2%w/v Lidocaine Hydrochloride Injection, USP

    Suppression of ventricular extrasystoles and ventricular tachycardia, especially after an acute myocardial infarction. Local anaesthesia by surface infiltration, regional, epidural and caudal routes, dental anaesthesia, either alone or in combination with adrenaline. Lidocaine may also be administered by s...

Qatar Pharma resources (1)